154 related articles for article (PubMed ID: 8779306)
1. Ganglioside GM1 and GM3 in early human brain development: an immunocytochemical study.
Stojiljković M; Blagojević T; Vukosavić S; Zvezdina ND; Peković S; Nikezić G; Rakić L
Int J Dev Neurosci; 1996 Feb; 14(1):35-44. PubMed ID: 8779306
[TBL] [Abstract][Full Text] [Related]
2. Distribution of gangliosides, GM1 and GM3, in the rat oviduct.
Choo YK
Mol Cells; 1999 Feb; 9(1):56-60. PubMed ID: 10102572
[TBL] [Abstract][Full Text] [Related]
3. Ganglioside composition in human meningiomas.
Davidsson P; Fredman P; Collins VP; von Holst H; Mänsson JE; Svennerholm L
J Neurochem; 1989 Sep; 53(3):705-9. PubMed ID: 2760617
[TBL] [Abstract][Full Text] [Related]
4. Rapid internalization of exogenous ganglioside GM3 and its metabolism to ceramide in human myelogenous leukemia HL-60 cells compared with control ganglioside GM1.
Nakamura M; Tsunoda A; Furukawa Y; Sakai T; Saito M
FEBS Lett; 1997 Jan; 400(3):350-4. PubMed ID: 9009229
[TBL] [Abstract][Full Text] [Related]
5. Preparation of various lysogangliosides including lyso-fucosyl GM1 and delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometric analysis.
Taketomi T; Hara A; Uemura K; Kurahashi H; Sugiyama E
J Biochem; 1997 Feb; 121(2):264-9. PubMed ID: 9089399
[TBL] [Abstract][Full Text] [Related]
6. Differential uPAR recruitment in caveolar-lipid rafts by GM1 and GM3 gangliosides regulates endothelial progenitor cells angiogenesis.
Margheri F; Papucci L; Schiavone N; D'Agostino R; Trigari S; Serratì S; Laurenzana A; Biagioni A; Luciani C; Chillà A; Andreucci E; Del Rosso T; Margheri G; Del Rosso M; Fibbi G
J Cell Mol Med; 2015 Jan; 19(1):113-23. PubMed ID: 25313007
[TBL] [Abstract][Full Text] [Related]
7. Oriented 1,2-dimyristoyl-sn-glycero-3-phosphorylcholine/ganglioside membranes: a Fourier transform infrared attenuated total reflection spectroscopic study. Band assignments; orientational, hydrational, and phase behavior; and effects of Ca2+ binding.
Müller E; Giehl A; Schwarzmann G; Sandhoff K; Blume A
Biophys J; 1996 Sep; 71(3):1400-21. PubMed ID: 8874015
[TBL] [Abstract][Full Text] [Related]
8. Ganglioside composition of astrocytes.
Asou H; Hirano S; Uyemura K
Cell Struct Funct; 1989 Oct; 14(5):561-8. PubMed ID: 2515920
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic effect of ganglioside GM1 and GM3 on the activity and conformation of sarcoplasmic reticulum Ca(2+)-ATPase.
Wang Y; Tsui Z; Yang F
FEBS Lett; 1999 Aug; 457(1):144-8. PubMed ID: 10486582
[TBL] [Abstract][Full Text] [Related]
10. Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation.
Bremer EG; Hakomori S; Bowen-Pope DF; Raines E; Ross R
J Biol Chem; 1984 Jun; 259(11):6818-25. PubMed ID: 6327695
[TBL] [Abstract][Full Text] [Related]
11. Gangliosides GM1 and GM3 in the living cell membrane form clusters susceptible to cholesterol depletion and chilling.
Fujita A; Cheng J; Hirakawa M; Furukawa K; Kusunoki S; Fujimoto T
Mol Biol Cell; 2007 Jun; 18(6):2112-22. PubMed ID: 17392511
[TBL] [Abstract][Full Text] [Related]
12. A procedure for the preparation of GM3 ganglioside from GM1-lactone.
Mauri L; Casellato R; Kirschner G; Sonnino S
Glycoconj J; 1999 Mar; 16(3):197-203. PubMed ID: 10596894
[TBL] [Abstract][Full Text] [Related]
13. Comparison and Possible Binding Orientations of SARS-CoV-2 Spike N-Terminal Domain for Gangliosides GM3 and GM1.
Das T; Mukhopadhyay C
J Phys Chem B; 2023 Aug; 127(31):6940-6948. PubMed ID: 37523476
[TBL] [Abstract][Full Text] [Related]
14. [Gangliosides GM3 and GD3 in human stomach and breast tumors].
Diatlovitskaia EV; Tekieva EA; Lemenovskaia AF; Somova OG; Bergel'son LD
Biokhimiia; 1991 Mar; 56(3):560-4. PubMed ID: 1883911
[TBL] [Abstract][Full Text] [Related]
15. Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides.
Di Pasquale E; Fantini J; Chahinian H; Maresca M; Taïeb N; Yahi N
J Mol Biol; 2010 Mar; 397(1):202-18. PubMed ID: 20114052
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic study of modulation of SR Ca2+-ATPpase activity by gangliosides GM1 and GM3 through some biophysical measurements.
Wang Y; Tsui Z; Yang F
Glycoconj J; 1999 Dec; 16(12):781-6. PubMed ID: 11133018
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of biofunctional GM1 and GM3 gangliosides within the plastic-adherent multipotent mesenchymal stromal cell population.
Freund D; Fonseca AV; Janich P; Bornhäuser M; Corbeil D
Cytotherapy; 2010 Apr; 12(2):131-42. PubMed ID: 20196693
[TBL] [Abstract][Full Text] [Related]
18. Gangliosides GM1, GM2 and GM3 inhibit the platelet-derived growth factor-induced signalling transduction pathway in vascular smooth muscle cells by different mechanisms.
Sachinidis A; Kraus R; Seul C; Meyer zu Brickwedde MK; Schulte K; Ko Y; Hoppe J; Vetter H
Eur J Cell Biol; 1996 Sep; 71(1):79-88. PubMed ID: 8884181
[TBL] [Abstract][Full Text] [Related]
19. Myelin gangliosides of human peripheral nervous system: an enrichment of GM1 in the motor nerve myelin isolated from cauda equina.
Ogawa-Goto K; Funamoto N; Ohta Y; Abe T; Nagashima K
J Neurochem; 1992 Nov; 59(5):1844-9. PubMed ID: 1402926
[TBL] [Abstract][Full Text] [Related]
20. Increased Expression of Simple Ganglioside Species GM2 and GM3 Detected by MALDI Imaging Mass Spectrometry in a Combined Rat Model of Aβ Toxicity and Stroke.
Caughlin S; Hepburn JD; Park DH; Jurcic K; Yeung KK; Cechetto DF; Whitehead SN
PLoS One; 2015; 10(6):e0130364. PubMed ID: 26086081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
